Allegro biotech (private company)

See something wrong or missing? Let us know
Offices:Gent
Business model:B2B

Allegro is a Belgium-based heatlh startup developing a custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.04M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Allegro biotech

Name Criteria
France PEP-Therapy
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France DeepLife
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Netherlands CimCure
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Biorelate
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom OxCan
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom iLoF
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Monocl
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Ireland ONK Therapeutics
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain Veritas Intercontinental
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Poland GeneMe
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top